The ornithine decarboxylase inhibitor α-difluoromethylornithine, used to treat African sleeping sickness and unwanted hair growth, may also protect β cells of people with new-onset type 1 diabetes.
People with diabetes who have a positive sense of humor appear to have better glucose control, indicates research suggesting humor training could be incorporated into patient management.
There is significant unmet medical need in gastroparesis, and compared with cannabis, CBD has limited psychic effects with the added potential to reduce gut sensation and inflammation.
A new Cochrane Review based on published and unpublished data finds that unopened insulin can last for up to 6 months and at temperatures up to 25°C (77°F).